The Cure Alzheimer’s Fund has recognized the outstanding contributions of Dr. Andrew S. Yoo and Dr. Zhao Sun from Washington University School of Medicine in St. Louis with the second annual Jeffrey L. Morby Prize. Their research, published in Science in August 2024, introduces a novel method for studying aged neurons in the laboratory, bypassing the need for brain biopsies. This advancement allows for more accurate modeling of late-onset Alzheimer’s disease (AD), offering new avenues for understanding its development and exploring potential treatments.
The Morby Prize, established in memory of Cure Alzheimer’s Fund Co-Founder Jeffrey L. Morby, celebrates research that significantly advances the understanding of Alzheimer’s disease. The award includes a $200,000 grant to support further Alzheimer’s-related research in Dr. Yoo’s lab. This year’s recipients were chosen by their peers, highlighting the scientific community’s recognition of their work’s importance.
Dr. Yoo and Dr. Sun’s study focuses on transforming skin cells from patients into neurons that accurately reflect the aging process. This method enables scientists to observe critical disease features, such as amyloid beta plaque buildup, in a controlled environment. Such insights are crucial for developing targeted therapies that could prevent, slow, or reverse Alzheimer’s disease.
The implications of this research are profound. By providing a more accurate model of late-onset Alzheimer’s, scientists can better understand how aging contributes to neurodegeneration. This understanding is vital for developing treatments that address the root causes of the disease, rather than just its symptoms. The Morby Prize not only honors the legacy of Jeffrey L. Morby but also underscores the importance of innovative research in the fight against Alzheimer’s disease.
With Alzheimer’s disease affecting millions worldwide and posing significant challenges to healthcare systems, the work of Dr. Yoo and Dr. Sun represents a beacon of hope. Their research could lead to breakthroughs in treatment and prevention, significantly impacting patients, families, and societies globally. The Cure Alzheimer’s Fund’s support of such pioneering research exemplifies the critical role of philanthropy in advancing scientific discovery and improving human health.
